Amy Meng
Impact in
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Urticaria and Related Conditions
-
- Autoimmune and Inflammatory Disorders Research
Papers in
- Co-authors
- Bernard P. Murray (3 shared papers)Julie A. Di Paolo (4 shared papers)Federico Campigotto (2 shared papers)Paqui G. Través (1 shared paper)René Galien (1 shared paper)Anita Mathias (4 shared papers)Polina German (1 shared paper)Liyun Ni (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (5 papers)British Journal of Clinical Pharmacology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)The Journal of Clinical Pharmacology (1 paper)Journal of Crohn s and Colitis (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Amy Meng
9 papers receiving 269 citations
Amy Meng's Hit Papers
Peers
Comparison fields: 5 of 45
- Rheumatology 105
- Hematology 36
- Genetics 32
- Oncology 75
- Dermatology 21
Countries citing papers authored by Amy Meng
This map shows the geographic impact of Amy Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Meng more than expected).
Fields of papers citing papers by Amy Meng
This network shows the impact of papers produced by Amy Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Meng. The network helps show where Amy Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib Hit paper breakdown → | 2021 | 240 |
| 2 | 2018 | 10 | |
| 3 | 2022 | 7 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 3 | |
| 6 | 2019 | 2 | |
| 7 | 2019 | 2 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 0 | |
| 11 | 2016 | 0 |
About Amy Meng
Amy Meng is a scholar working on Genetics, Oncology, Rheumatology, Infectious Diseases and Pathology and Forensic Medicine, having authored 11 papers that have together received 271 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Cytokine Signaling Pathways and Interactions (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Chronic Myeloid Leukemia Treatments (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Rheumatology (105 citations), Hematology (36 citations), Genetics (32 citations), Oncology (75 citations) and Dermatology (21 citations). Amy Meng has collaborated with scholars based in United States and France. Frequent co-authors include Bernard P. Murray, Julie A. Di Paolo, Federico Campigotto, Paqui G. Través, René Galien, Anita Mathias, Polina German, Liyun Ni, Sandra A. Lewis and John Ling. Their work appears in journals such as Annals of the Rheumatic Diseases, British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology and Journal of Crohn s and Colitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.